Urokinase 250000IU Injection

Get a Price/Quote

MOQ : 10000 Boxes

Urokinase 250000IU Injection Specification

Salt Composition
Urokinase 250,000 IU

Indication
Thromboembolic disorders, occluded IV catheters

Dosage Form
Lyophilized powder for reconstitution

Origin of Medicine
Allopathic

Pacakaging (Quantity Per Box)
1 vial per box

Drug Type
Prescription medicine

Ingredients
Urokinase 250,000 IU

Physical Form
Injection

Function
Thrombolytic agent for dissolving blood clots

Recommended For
Treatment of pulmonary embolism, myocardial infarction, and deep vein thrombosis

Dosage
As directed by the physician

Dosage Guidelines
Reconstitute with sterile water, administer as per physicians prescription

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store below 25C, protect from light and moisture

About Urokinase 250000IU Injection

Product Description

We Rewine Pharmaceutical are a leading Manufacturer and Exporter of Urokinase 250000 I.U injection in different strength and packing. Our manufacturing facility is certified with WHO-GMP.

Composition:

Urokinase 5 Lacks I.U

Urokinase 2.5 Lacks I.U

Product Type: Finished Product

Dose/Strength (ex. 1 mg or 1 ml): 15 Lacks I.U

Type: vial

Usage: Clinical, Hospital

We manufacture and export our brand. We also offer private labelling, Contract manufacturing service.

Reliable Thrombolytic Therapy

UNIKINASE delivers targeted thrombolytic action to dissolve blood clots in adults suffering from conditions such as deep vein thrombosis, pulmonary embolism, and myocardial infarction. With WHO-GMP certification, it assures stringent quality standards for confident clinical use.

Convenient Single-Dose Presentation

Each vial contains 250,000 IU of urokinase in lyophilized powder form to be reconstituted with sterile water prior to administration. The single-dose presentation simplifies dosage calculation and preparation, ensuring optimal efficacy during clinical emergencies.

Comprehensive Safety Profile

UNIKINASE should be administered strictly as per physicians instructions, considering contraindications such as active internal bleeding or severe uncontrolled hypertension. Common side effects may include bleeding, allergic reactions, and hypotension, underscoring the importance of medical supervision.

FAQs of Urokinase 250000IU Injection:

Q: How should UNIKINASE (Urokinase 250,000 IU) Injection be prepared and administered?

A: UNIKINASE should be reconstituted using sterile water for injection as directed in the products instructions. It is administered intravenously by a healthcare professional, either as an injection or infusion, depending on the prescribed protocol.

Q: What are the main indications for using UNIKINASE Injection?

A: UNIKINASE is indicated for the treatment of thromboembolic disorders, including pulmonary embolism, myocardial infarction, and deep vein thrombosis, as well as for clearing occluded intravenous catheters.

Q: When is UNIKINASE contraindicated?

A: UNIKINASE should not be used in patients with active internal bleeding, recent cerebrovascular accident, or severe uncontrolled hypertension due to an increased risk of complications.

Q: Where should UNIKINASE vials be stored for maximum shelf life?

A: UNIKINASE should be stored below 25C, protected from light and moisture, to ensure its stability and maintain the full 24-month shelf life from the manufacturing date.

Q: What should patients be aware of regarding possible side effects when receiving UNIKINASE?

A: Patients should be monitored for potential side effects such as bleeding, allergic reactions, and hypotension during and after administration. Report any unusual symptoms to a healthcare provider immediately.

Q: What are the therapeutic benefits of using a fibrinolytic agent like UNIKINASE?

A: UNIKINASE works by dissolving problematic blood clots, which can restore normal blood flow and reduce the risk of serious complications caused by thromboembolic events, facilitating rapid clinical improvement.

Q: Is UNIKINASE suitable for pediatric patients or specific populations?

A: UNIKINASE is recommended for adult use only and should be administered strictly under physician supervision based on established dosage guidelines.

Tell us about your requirement